Biogen's Alzheimer's drug aducanumab, if approved, may face extra hurdles, slow sales ramp: analysts
anonymous Guest anonymous   Jun 02, 2021 at 01:24: PM #1 anonymous Guest Biogen's Alzheimer's drug aducanumab, if approved, may face extra hurdles, slow sales ramp: analysts
anonymous Guest anonymous   Jun 02, 2021 at 03:35: PM #2 anonymous Guest Never. Getting. Prescribed.
anonymous Guest anonymous   Jun 02, 2021 at 04:35: PM #3 anonymous Guest anonymous said: Never. Getting. Prescribed. Click to expand... Is it Never. Getting. Approved or Never.Getting.Prescribed? Which one is it?
anonymous said: Never. Getting. Prescribed. Click to expand... Is it Never. Getting. Approved or Never.Getting.Prescribed? Which one is it?
anonymous Guest anonymous   Jun 03, 2021 at 02:05: PM #4 anonymous Guest anonymous said: Is it Never. Getting. Approved or Never.Getting.Prescribed? Which one is it? Click to expand... If it never gets approved it never gets prescribed.
anonymous said: Is it Never. Getting. Approved or Never.Getting.Prescribed? Which one is it? Click to expand... If it never gets approved it never gets prescribed.
anonymous Guest anonymous   Jun 03, 2021 at 02:35: PM #5 anonymous Guest anonymous said: If it never gets approved it never gets prescribed. Click to expand... Very True.